139 related articles for article (PubMed ID: 37786444)
1. Clinical association and diagnostic significance of miRNA-29a and miRNA-147b in type 2 diabetes mellitus.
Dzung PT; Trung NT; Van Khanh L; Chinh DD; Van De D; Van Tong H; Toan NL
Int J Med Sci; 2023; 20(10):1316-1325. PubMed ID: 37786444
[No Abstract] [Full Text] [Related]
2. Investigation of the levels of circulating miR-29a, miR-122, sestrin 2 and inflammatory markers in obese children with/without type 2 diabetes: a case control study.
Mohany KM; Al Rugaie O; Al-Wutayd O; Al-Nafeesah A
BMC Endocr Disord; 2021 Aug; 21(1):152. PubMed ID: 34344352
[TBL] [Abstract][Full Text] [Related]
3. Yunpi Heluo decoction attenuates insulin resistance by regulating liver miR-29a-3p in Zucker diabetic fatty rats.
Mao ZJ; Weng SY; Lin M; Chai KF
J Ethnopharmacol; 2019 Oct; 243():111966. PubMed ID: 31128151
[TBL] [Abstract][Full Text] [Related]
4. hsa-miR-607, lncRNA TUG1 and hsa_circ_0071106 can be combined as biomarkers in type 2 diabetes mellitus.
Su M; Yu T; Yu Y; Cheng Q; Zheng Y; Liao R; Zeng Z
Exp Biol Med (Maywood); 2022 Sep; 247(18):1609-1618. PubMed ID: 35876150
[TBL] [Abstract][Full Text] [Related]
5. Significance of serum miR-29a in the occurrence and progression of diabetic nephropathy: A cross-sectional study.
Liu Q; Wang M; Xu T; Liang W; Yang F
J Clin Lab Anal; 2022 Feb; 36(2):e24210. PubMed ID: 34964177
[TBL] [Abstract][Full Text] [Related]
6. Increased microRNA-146a levels in plasma of patients with newly diagnosed type 2 diabetes mellitus.
Rong Y; Bao W; Shan Z; Liu J; Yu X; Xia S; Gao H; Wang X; Yao P; Hu FB; Liu L
PLoS One; 2013; 8(9):e73272. PubMed ID: 24023848
[TBL] [Abstract][Full Text] [Related]
7. Circulating microRNAs as predictive biomarkers of coronary artery diseases in type 2 diabetes patients.
Mahjoob G; Ahmadi Y; Fatima Rajani H; Khanbabaei N; Abolhasani S
J Clin Lab Anal; 2022 May; 36(5):e24380. PubMed ID: 35349731
[TBL] [Abstract][Full Text] [Related]
8. Identification of Neuroendocrine Stress Response-Related Circulating MicroRNAs as Biomarkers for Type 2 Diabetes Mellitus and Insulin Resistance.
Liang YZ; Dong J; Zhang J; Wang S; He Y; Yan YX
Front Endocrinol (Lausanne); 2018; 9():132. PubMed ID: 29643835
[TBL] [Abstract][Full Text] [Related]
9. Altered profile of serum microRNAs in pancreatic cancer-associated new-onset diabetes mellitus.
Dai X; Pang W; Zhou Y; Yao W; Xia L; Wang C; Chen X; Zen K; Zhang CY; Yuan Y
J Diabetes; 2016 May; 8(3):422-33. PubMed ID: 25991015
[TBL] [Abstract][Full Text] [Related]
10. Affection of single-nucleotide polymorphisms in miR-27a, miR-124a, and miR-146a on susceptibility to type 2 diabetes mellitus in Chinese Han people.
Wang TT; Chen YJ; Sun LL; Zhang SJ; Zhou ZY; Qiao H
Chin Med J (Engl); 2015 Feb; 128(4):533-9. PubMed ID: 25673459
[TBL] [Abstract][Full Text] [Related]
11. Increased plasma miR-146a levels are associated with subclinical atherosclerosis in newly diagnosed type 2 diabetes mellitus.
Guo W; Li XN; Li J; Lu J; Wu J; Zhu WF; Qin P; Xu NZ; Zhang Q
J Diabetes Complications; 2020 Dec; 34(12):107725. PubMed ID: 32981813
[TBL] [Abstract][Full Text] [Related]
12. Differential microRNA Profiles Predict Diabetic Nephropathy Progression in Taiwan.
Chien HY; Chen CY; Chiu YH; Lin YC; Li WC
Int J Med Sci; 2016; 13(6):457-65. PubMed ID: 27279796
[TBL] [Abstract][Full Text] [Related]
13. MiRNAs profile as biomarkers of nutritional therapy for the prevention of type 2 diabetes mellitus: From the CORDIOPREV study.
Jimenez-Lucena R; Alcala-Diaz JF; Roncero-Ramos I; Lopez-Moreno J; Camargo A; Gomez-Delgado F; Quintana-Navarro GM; Vals-Delgado C; Rodriguez-Cantalejo F; Luque RM; Delgado-Lista J; Ordovas JM; Perez-Martinez P; Rangel-Zuñiga OA; Lopez-Miranda J
Clin Nutr; 2021 Mar; 40(3):1028-1038. PubMed ID: 32723508
[TBL] [Abstract][Full Text] [Related]
14. Assessment of Cell-Free Long Non-Coding RNA-H19 and miRNA-29a, miRNA-29b Expression and Severity of Diabetes.
Alfaifi M; Verma AK; Alshahrani MY; Joshi PC; Alkhathami AG; Ahmad I; Hakami AR; Beg MMA
Diabetes Metab Syndr Obes; 2020; 13():3727-3737. PubMed ID: 33116722
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-147b induces neuroendocrine differentiation of prostate cancer cells by targeting ribosomal protein RPS15A.
Natani S; Ramakrishna M; Nallavolu T; Ummanni R
Prostate; 2023 Jul; 83(10):936-949. PubMed ID: 37069746
[TBL] [Abstract][Full Text] [Related]
16. Circulating miR-147b as a diagnostic marker for patients with bacterial sepsis and septic shock.
Trung NT; Lien TT; Sang VV; Hoan NX; Manh ND; Thau NS; Quyen DT; Hien TTT; Hoan PQ; Bang MH; Velavan TP; Song LH
PLoS One; 2021; 16(12):e0261228. PubMed ID: 34914790
[TBL] [Abstract][Full Text] [Related]
17. Early-Onset Diabetes as Risk Factor for Pancreatic Cancer: miRNA Expression Profiling in Plasma Uncovers a Role for miR-20b-5p, miR-29a, and miR-18a-5p in Diabetes of Recent Diagnosis.
Tavano F; Fontana A; Mazza T; Gioffreda D; Biagini T; Palumbo O; Carella M; Andriulli A
Front Oncol; 2020; 10():1567. PubMed ID: 33072549
[TBL] [Abstract][Full Text] [Related]
18. Expression of miR-18a and miR-34c in circulating monocytes associated with vulnerability to type 2 diabetes mellitus and insulin resistance.
Wang SS; Li YQ; Liang YZ; Dong J; He Y; Zhang L; Yan YX
J Cell Mol Med; 2017 Dec; 21(12):3372-3380. PubMed ID: 28661068
[TBL] [Abstract][Full Text] [Related]
19. Association of rs2910164 in miR-146a with type 2 diabetes mellitus: A case-control and meta-analysis study.
Chang WW; Wen LY; Zhang L; Tong X; Jin YL; Chen GM
Front Endocrinol (Lausanne); 2022; 13():961635. PubMed ID: 36237193
[TBL] [Abstract][Full Text] [Related]
20. Circulating microRNA-122, microRNA-126-3p and microRNA-146a are associated with inflammation in patients with pre-diabetes and type 2 diabetes mellitus: A case control study.
Zeinali F; Aghaei Zarch SM; Jahan-Mihan A; Kalantar SM; Vahidi Mehrjardi MY; Fallahzadeh H; Hosseinzadeh M; Rahmanian M; Mozaffari-Khosravi H
PLoS One; 2021; 16(6):e0251697. PubMed ID: 34077450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
